Clinical drug trials are triggering an increasing number of lawsuits, ranging from wrongful death claims to actions to enforce the right to continue receiving drugs. With about 50,000 clinical trials currently under way in the United States, plaintiffs have expanded their targets to include doctors, universities, research institutions, drug companies -- even patent holders of certain medical devices. Some believe that public mistrust of the medical community is driving the litigation.
Drug Trials on Trial
The National Law Journal
July 21, 2005
This article requires premium access
This article requires premium access to Law.com. Please sign in or subscribe to read the full text.